IPOS - Immune Disease-Focused Alumis Raises $250M In Downsized Initial Public Offering | Benzinga
On Friday, Alumis Inc (NASDAQ:ALMS) priced its initial public offering at $16/share, the low end of the range of $16 to $18, raising $210 million via 13.13 million shares offering.
Earlier, the company anticipated offering 17.65 million, raising $274 million and $315 million if the underwriters' over-allotment option is fully exercised.
In addition, Alumis has granted the underwriters a 30-day over-allotment option to purchase up to an additional 1,968,750 shares.
In addition to the shares being sold in the initial public offering, Alumis also announced that it has agreed ...